Publication | Closed Access
Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
65
Citations
17
References
2020
Year
Radiation OncologyRecurrent MalignanciesMalignant DiseasePd-1 MabMedicineImmunologyPathologyImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyClinical Efficacy
| Year | Citations | |
|---|---|---|
Page 1
Page 1